{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:58:36Z","timestamp":1790283516721,"version":"4.1.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vph.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T16:18:01Z","timestamp":1539793081000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta"],"prefix":"10.1016","volume":"112","author":[{"given":"Johanna P.","family":"Laakkonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"L\u00e4hteenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Jauhiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Heikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-2708","authenticated-orcid":false,"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.vph.2018.10.005_bb0005","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1074\/jbc.270.52.31189","article-title":"Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells","volume":"270","author":"Namiki","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer","volume":"77","author":"Liu","year":"1995","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1172\/JCI118437","article-title":"Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression","volume":"97","author":"Brogi","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","article-title":"VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses","volume":"92","author":"Rissanen","year":"2003","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.CIR.0000115519.03688.A2","article-title":"Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart","volume":"109","author":"Rutanen","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.108.816454","article-title":"Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms","volume":"119","author":"Lahteenvuo","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.vph.2018.10.005_bb0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/10739680902997333","article-title":"Molecular diversity of VEGF-A as a regulator of its biological activity","volume":"16","author":"Woolard","year":"2009","journal-title":"Microcirculation"},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.CIR.0000115519.03688.A2","article-title":"Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart","volume":"109","author":"Rutanen","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2013.11.002","article-title":"Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning","volume":"25","author":"Vempati","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.mvr.2010.03.014","article-title":"Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction","volume":"80","author":"Zhao","year":"2010","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.108.816454","article-title":"Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms","volume":"119","author":"Lahteenvuo","year":"2009","journal-title":"Circulation"},{"issue":"4-5","key":"10.1016\/j.vph.2018.10.005_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of vascular permeability by vascular endothelial growth factors","volume":"39","author":"Bates","year":"2002","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-016-9532-7","article-title":"Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling, transcription factor SNAI2 and interleukin-8","volume":"20","author":"Laakkonen","year":"2017","journal-title":"Angiogenesis"},{"issue":"7058","key":"10.1016\/j.vph.2018.10.005_bb0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacbts.2017.02.005","article-title":"Cardiac lymphatic vessels, transport, and healing of the infarcted heart","volume":"2","author":"Huang","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tem.2016.12.002","article-title":"Cardiac lymphatics \u2013 a new avenue for therapeutics?","volume":"28","author":"Vuorio","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/micc.12220","article-title":"VEGF pathways in the lymphatics of healthy and diseased heart","volume":"23","author":"Dashkevich","year":"2016","journal-title":"Microcirculation"},{"issue":"7554","key":"10.1016\/j.vph.2018.10.005_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature14483","article-title":"Cardiac lymphatics are heterogeneous in origin and respond to injury","volume":"522","author":"Klotz","year":"2015","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.vph.2018.10.005_bb0100","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.115.020143","article-title":"Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction","volume":"133","author":"Henri","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.vph.2018.10.005_bb0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J. Exp. Med."},{"issue":"7560","key":"10.1016\/j.vph.2018.10.005_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0115","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/ATVBAHA.114.302528","article-title":"Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis","volume":"34","author":"Vuorio","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb0120","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1172\/JCI77162","article-title":"A lymphatic defect causes ocular hypertension and glaucoma in mice","volume":"124","author":"Thomson","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0125","doi-asserted-by":"crossref","first-page":"H1173","DOI":"10.1152\/ajpheart.00411.2011","article-title":"Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-beta and VEGFR-2 expression","volume":"302","author":"Chanakira","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mvre.1999.2171","article-title":"Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro","volume":"58","author":"Grosskreutz","year":"1999","journal-title":"Microvasc. Res."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jcp.1121","article-title":"Expression of vascular endothelial growth factor receptors in smooth muscle cells","volume":"188","author":"Ishida","year":"2001","journal-title":"J. Cell. Physiol."},{"issue":"94","key":"10.1016\/j.vph.2018.10.005_bb0140","first-page":"115","article-title":"Role of pericytes in vascular morphogenesis","volume":"94","author":"Betsholtz","year":"2005","journal-title":"EXS"},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb0150","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1096\/fj.09-149070","article-title":"Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment","volume":"24","author":"Lorquet","year":"2010","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0008-6363(02)00326-7","article-title":"Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1\/VEGF-receptor-1","volume":"55","author":"Parenti","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"18","key":"10.1016\/j.vph.2018.10.005_bb0160","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.102.18.2262","article-title":"Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta","volume":"102","author":"Hiltunen","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000442885","article-title":"Evaluation of vascular endothelial growth factor and its receptors in human neointima","volume":"83","author":"Bruczko","year":"2016","journal-title":"Pathobiology"},{"issue":"12","key":"10.1016\/j.vph.2018.10.005_bb0170","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1161\/01.ATV.0000147161.42956.80","article-title":"Essential role of vascular endothelial growth factor and flt-1 signals in neointimal formation after periadventitial injury","volume":"24","author":"Zhao","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.vph.2018.10.005_bb0175","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/01.CIR.0000145120.37891.8A","article-title":"Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury","volume":"110","author":"Hutter","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0180","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.ATV.0000128127.57688.e0","article-title":"Vascular endothelial growth factor gene transfer inhibits neointimal macrophage accumulation in hypercholesterolemic rabbits","volume":"24","author":"Khurana","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0185","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/cvr\/cvt148","article-title":"The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models","volume":"99","author":"Heinonen","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"1-2","key":"10.1016\/j.vph.2018.10.005_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-015-2622-9","article-title":"Vascular endothelial growth factor-C protects heart from ischemia\/reperfusion injury by inhibiting cardiomyocyte apoptosis","volume":"413","author":"Chen","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0195","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1096\/fj.09-143180","article-title":"Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction","volume":"24","author":"Zentilin","year":"2010","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0200","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1096\/fj.201700761RR","article-title":"Effects of chronically increased VEGF-A on the aging heart","volume":"32","author":"Marneros","year":"2018","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0205","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13096","article-title":"Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B167: echocardiography and magnetic resonance imaging study","volume":"5","author":"Lottonen-Raikaslehto","year":"2017","journal-title":"Physiol. Rep."},{"issue":"9","key":"10.1016\/j.vph.2018.10.005_bb0210","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCRESAHA.108.178459","article-title":"Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy","volume":"103","author":"Karpanen","year":"2008","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0215","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.ijcard.2012.06.127","article-title":"Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart","volume":"167","author":"Zhao","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10739680600556811","article-title":"Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: influence of acute ischemia\/cardioplegia and reperfusion","volume":"13","author":"Wang","year":"2006","journal-title":"Microcirculation"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.RES.0000014823.75393.4D","article-title":"Autocrine regulation of myocyte Cx43 expression by VEGF","volume":"90","author":"Pimentel","year":"2002","journal-title":"Circ. Res."},{"issue":"17-18","key":"10.1016\/j.vph.2018.10.005_bb0230","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/ten.tea.2011.0468","article-title":"Vascular endothelial growth factor secretion by nonmyocytes modulates connexin-43 levels in cardiac organoids","volume":"18","author":"Iyer","year":"2012","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.vph.2018.10.005_bb0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fphys.2017.00373","article-title":"Vascular endothelial growth factor-B induces a distinct electrophysiological phenotype in mouse heart","volume":"8","author":"Naumenko","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2018.10.005_bb0240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.biopha.2016.11.082","article-title":"Enhanced effect of VEGF165 on L-type calcium currents in guinea-pig cardiac ventricular myocytes","volume":"85","author":"Xing","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0245","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171089","article-title":"The role of vascular endothelial growth factor-B in metabolic homoeostasis: current evidence","volume":"37","author":"Zafar","year":"2017","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0250","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/emmm.201303147","article-title":"VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart","volume":"6","author":"Kivela","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"7290","key":"10.1016\/j.vph.2018.10.005_bb0255","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature08945","article-title":"Vascular endothelial growth factor B controls endothelial fatty acid uptake","volume":"464","author":"Hagberg","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"issue":"1-2","key":"10.1016\/j.vph.2018.10.005_bb0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11010-015-2646-1","article-title":"Vascular endothelial growth factor-D mediates fibrogenic response in myofibroblasts","volume":"413","author":"Zhao","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-2828(03)00006-3","article-title":"Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors flt-1 and KDR","volume":"35","author":"Chintalgattu","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0275","doi-asserted-by":"crossref","first-page":"H789","DOI":"10.1152\/ajpheart.00559.2013","article-title":"Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis","volume":"306","author":"Zhao","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb0280","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","article-title":"VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses","volume":"92","author":"Rissanen","year":"2003","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0285","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.stemcr.2015.10.019","article-title":"Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions","volume":"5","author":"Yamakawa","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"7400","key":"10.1016\/j.vph.2018.10.005_bb0290","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.vph.2018.10.005_bb0295","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1091\/mbc.e17-01-0014","article-title":"Mechanical regulation of cardiac fibroblast profibrotic phenotypes","volume":"28","author":"Herum","year":"2017","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0300","first-page":"404","article-title":"Homing of stem cells to ischemic myocardium","volume":"5","author":"Taghavi","year":"2013","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb0305","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0802-775","article-title":"VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies","volume":"8","author":"Eriksson","year":"2002","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0310","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/ATVBAHA.116.307303","article-title":"Vascular regeneration by stem\/progenitor cells","volume":"36","author":"Xie","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0315","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cardiores.2005.09.010","article-title":"Questioning the relevance of circulating cardiac progenitor cells in cardiac regeneration","volume":"68","author":"Zimmermann","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0320","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.0000137878.26174.66","article-title":"Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences","volume":"95","author":"Kinnaird","year":"2004","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0325","doi-asserted-by":"crossref","first-page":"H1653","DOI":"10.1152\/ajpheart.00363.2005","article-title":"Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells","volume":"291","author":"Chen","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2018.10.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc01f05s6","article-title":"Endothelial differentiation of embryonic stem cells","author":"Blancas","year":"2008","journal-title":"Curr. Protoc. Stem Cell Biol."},{"issue":"15","key":"10.1016\/j.vph.2018.10.005_bb0335","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.22-15-06401.2002","article-title":"Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and akt","volume":"22","author":"Wick","year":"2002","journal-title":"J. Neurosci."},{"issue":"48","key":"10.1016\/j.vph.2018.10.005_bb0340","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1073\/pnas.1407227111","article-title":"VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions","volume":"111","author":"Guaiquil","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0345","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0008-6363(00)00308-4","article-title":"Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death","volume":"50","author":"Chen","year":"2001","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191040","article-title":"VEGF may contribute to macrophage recruitment and M2 polarization in the decidua","volume":"13","author":"Wheeler","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0355","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1095\/biolreprod51.3.524","article-title":"Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells","volume":"51","author":"Charnock-Jones","year":"1994","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0360","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1530\/jrf.0.1050205","article-title":"Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry","volume":"105","author":"Cooper","year":"1995","journal-title":"J. Reprod. Fertil."},{"issue":"11","key":"10.1016\/j.vph.2018.10.005_bb0365","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/hupa.2002.129420","article-title":"Expression of vascular endothelial growth factor, placental growth factor, and their receptors flt-1 and KDR in human placenta under pathologic conditions","volume":"33","author":"Kumazaki","year":"2002","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"De Falco","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0375","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/AOG.0000000000000232","article-title":"A practical approach to fetal growth restriction","volume":"123","author":"Copel","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.vph.2018.10.005_bb0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/CMPed.S40070","article-title":"Intrauterine growth restriction: antenatal and postnatal aspects","volume":"10","author":"Sharma","year":"2016","journal-title":"Clin. Med. Insights Pediatr."},{"key":"10.1016\/j.vph.2018.10.005_bb0385","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.preghy.2018.03.008","article-title":"Increased serum levels of sFlt-1\/PlGF ratio in preeclamptic women with onset at \/=32weeks","volume":"12","author":"Suzuki","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2018.10.005_bb0390","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.placenta.2017.09.011","article-title":"Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction","volume":"59","author":"David","year":"2017","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100021","article-title":"Local over-expression of VEGF-DDeltaNDeltaC in the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesis","volume":"9","author":"Mehta","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vph.2018.10.005_bb0400","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/hum.2016.046","article-title":"Maternal therapy with ad.VEGF-A165 increases fetal weight at term in a guinea-pig model of fetal growth restriction","volume":"27","author":"Swanson","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0405","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/uog.15880","article-title":"Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction","volume":"47","author":"Sheppard","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0410","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/humc.2017.090","article-title":"In vitro human placental studies to support adenovirus-mediated VEGF-D(DeltaNDeltaC) maternal gene therapy for the treatment of severe early-onset fetal growth restriction","volume":"29","author":"Desforges","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"issue":"10089","key":"10.1016\/j.vph.2018.10.005_bb0415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","article-title":"Infantile haemangioma","volume":"390","author":"Leaute-Labreze","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0420","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1623","article-title":"Inheritance patterns of infantile hemangioma","volume":"138","author":"Castren","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0425","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2214\/AJR.11.7852","article-title":"Vascular anomalies: hemangiomas and beyond--part 1, fast-flow lesions","volume":"200","author":"Behr","year":"2013","journal-title":"AJR Am. J. Roentgenol."},{"issue":"12","key":"10.1016\/j.vph.2018.10.005_bb0430","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archderm.138.12.1567","article-title":"Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex","volume":"138","author":"Chiller","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0435","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpeds.2006.12.003","article-title":"Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics","volume":"150","author":"Haggstrom","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vph.2018.10.005_bb0440","series-title":"Mulliken's and Young's Vascular Anomalies","author":"Mulliken","year":"2013"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0445","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/000155599750009834","article-title":"Increased expression of vascular endothelial growth factor in pyogenic granulomas","volume":"79","author":"Bragado","year":"1999","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0450","first-page":"59","article-title":"Benign vascular proliferations--an immunohistochemical and comparative study","volume":"55","author":"Dyduch","year":"2004","journal-title":"Pol. J. Pathol."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0455","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/DAD.0b013e318234e720","article-title":"Dilated lymphatic vessels in tufted angioma: a potential source of diagnostic confusion","volume":"34","author":"Sadeghpour","year":"2012","journal-title":"Am. J. Dermatopathol."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0460","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1203\/PDR.0b013e318163a243","article-title":"IGF-2 and FLT-1\/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma","volume":"63","author":"Picard","year":"2008","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0465","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/PAS.0b013e318243555b","article-title":"Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors","volume":"36","author":"Miettinen","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb0470","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archoto.2011.91","article-title":"Familial clustering of hemangiomas","volume":"137","author":"Grimmer","year":"2011","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0475","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-8628(19990101)82:1<77::AID-AJMG15>3.0.CO;2-A","article-title":"Genetic mapping of a novel familial form of infantile hemangioma","volume":"82","author":"Walter","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0480","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/gcc.10028","article-title":"Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma","volume":"33","author":"Walter","year":"2002","journal-title":"Genes Chromosom. Cancer"},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0485","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2008-06-162180","article-title":"Dusp-5 and snrk-1 coordinately function during vascular development and disease","volume":"113","author":"Pramanik","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.vph.2018.10.005_bb0490","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm.1877","article-title":"Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma","volume":"14","author":"Jinnin","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2018.10.005_bb0495","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13876","article-title":"VEGFR-2 conformational switch in response to ligand binding","volume":"5","author":"Sarabipour","year":"2016","journal-title":"elife"},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0500","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajhg.2016.06.010","article-title":"GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation","volume":"99","author":"Lim","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0505","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/JID.2015.376","article-title":"BRAF and RAS mutations in sporadic and secondary pyogenic granuloma","volume":"136","author":"Groesser","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0510","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajhg.2016.03.009","article-title":"Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma","volume":"98","author":"Ayturk","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.vph.2018.10.005_bb0515","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1161\/ATVBAHA.107.150284","article-title":"Hypoxia-induced mediators of stem\/progenitor cell trafficking are increased in children with hemangioma","volume":"27","author":"Kleinman","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0520","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","article-title":"Cellular markers that distinguish the phases of hemangioma during infancy and childhood","volume":"93","author":"Takahashi","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006534-199901000-00001","article-title":"Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis","volume":"103","author":"Chang","year":"1999","journal-title":"Plast. Reconstr. Surg."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0530","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.PRS.0000170804.80834.5F","article-title":"Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients","volume":"116","author":"Zhang","year":"2005","journal-title":"Plast. Reconstr. Surg."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0535","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2009.11.012","article-title":"Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth","volume":"49","author":"Przewratil","year":"2010","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0540","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/ATVBAHA.112.300929","article-title":"Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1","volume":"33","author":"Boscolo","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0545","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.188.6.1135","article-title":"Mast cells can secrete vascular permeability factor\/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression","volume":"188","author":"Boesiger","year":"1998","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0550","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10456-016-9494-9","article-title":"Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas","volume":"19","author":"Lee","year":"2016","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb0555","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"Leaute-Labreze","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.vph.2018.10.005_bb0560","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00431-015-2570-0","article-title":"Treatment of infantile haemangiomas: recommendations of a european expert group","volume":"174","author":"Hoeger","year":"2015","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0565","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bjd.14233","article-title":"Propranolol in the treatment of infantile haemangiomas: lessons from the european propranolol in the treatment of complicated haemangiomas (PITCH) taskforce survey","volume":"174","author":"Wedgeworth","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0570","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5966\/sctm.2015-0076","article-title":"Propranolol targets hemangioma stem cells via cAMP and mitogen-activated protein kinase regulation","volume":"5","author":"Munabi","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0575","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SLA.0b013e318254ce7a","article-title":"Propranolol induces regression of hemangioma cells through HIF-1alpha-mediated inhibition of VEGF-A","volume":"256","author":"Chim","year":"2012","journal-title":"Ann. Surg."},{"issue":"18","key":"10.1016\/j.vph.2018.10.005_bb0580","doi-asserted-by":"crossref","first-page":"13802","DOI":"10.1074\/jbc.275.18.13802","article-title":"Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta -adrenoreceptor\/cAMP\/protein kinase A pathway involving src but independently of Erk1\/2","volume":"275","author":"Fredriksson","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjd.12435","article-title":"Pathogenesis of infantile haemangioma","volume":"169","author":"Greenberger","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.vph.2018.10.005_bb0590","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bjoms.2012.12.003","article-title":"Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients","volume":"51","author":"Yuan","year":"2013","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0595","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/pde.12192","article-title":"Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy","volume":"30","author":"Chen","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.vph.2018.10.005_bb0600","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2016.05.002","article-title":"Serum and tissue profile of VEGF and its receptors VGFR1\/R2 in children with infantile hemangiomas on systemic propranolol treatment","volume":"175","author":"Przewratil","year":"2016","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0605","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/pde.13177","article-title":"Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase: a retrospective noninferiority study","volume":"34","author":"Bayart","year":"2017","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.vph.2018.10.005_bb0610","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14842","article-title":"Factors associated with delayed referral for infantile hemangioma necessitating propranolol","author":"Onnis","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.vph.2018.10.005_bb0615","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.16334","article-title":"Oral propranolol for infantile haemangioma may be associated with transient gross motor delay","author":"Mahon","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0620","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2016.02.1218","article-title":"Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4\u202fyears","volume":"75","author":"Moyakine","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.vph.2018.10.005_bb0625","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.2147\/IJN.S137634","article-title":"Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth","volume":"12","author":"Guo","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"21","key":"10.1016\/j.vph.2018.10.005_bb0630","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2217\/nnm-2017-0130","article-title":"PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma","volume":"12","author":"Guo","year":"2017","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0635","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3928\/01913913-20170703-12","article-title":"Combined oral and topical beta blockers for the treatment of early proliferative superficial periocular infantile capillary hemangioma","volume":"55","author":"Marey","year":"2018","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.vph.2018.10.005_bb0640","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fonc.2017.00137","article-title":"Topical application of 0.5% timolol maleate hydrogel for the treatment of superficial infantile hemangioma","volume":"7","author":"Wu","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.vph.2018.10.005_bb0645","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006534-199809010-00006","article-title":"Arteriovenous malformations of the head and neck: natural history and management","volume":"102","author":"Kohout","year":"1998","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.vph.2018.10.005_bb0650","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/PRS.0b013e3181d18070","article-title":"Extracranial arteriovenous malformations: natural progression and recurrence after treatment","volume":"125","author":"Liu","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.vph.2018.10.005_bb0655","series-title":"Vascular Anomalies","first-page":"94","article-title":"Management of arteriovenous malformations","author":"Greene","year":"2011"},{"key":"10.1016\/j.vph.2018.10.005_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nec.2011.09.012","article-title":"Arteriovenous malformations: epidemiology and clinical presentation","volume":"23","author":"Laakso","year":"2012","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.vph.2018.10.005_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.8","article-title":"Brain arteriovenous malformations","volume":"1","author":"Lawton","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.vph.2018.10.005_bb0670","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.vph.2018.10.005_bb0675","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.vph.2018.10.005_bb0680","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2006.041517","article-title":"SMAD4 mutations found in unselected HHT patients","volume":"43","author":"Gallione","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.vph.2018.10.005_bb0685","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/humu.22431","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation","volume":"34","author":"Revencu","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.vph.2018.10.005_bb0690","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","article-title":"BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia","volume":"93","author":"Wooderchak-Donahue","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.vph.2018.10.005_bb0695","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.116.026886","article-title":"Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling","volume":"136","author":"Amyere","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.10.005_bb0700","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/02688697.2013.815325","article-title":"Increased expression of vascular endothelial growth factor and its receptor in enlarging brain arteriovenous malformations--a case report","volume":"28","author":"Kashiwazaki","year":"2014","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.vph.2018.10.005_bb0705","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-7091-0693-8_14","article-title":"Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm","volume":"111","author":"Kim","year":"2011","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.vph.2018.10.005_bb0710","first-page":"818","article-title":"Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression","volume":"90","author":"Sadick","year":"2005","journal-title":"Haematologia"},{"key":"10.1016\/j.vph.2018.10.005_bb0715","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13650","article-title":"PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia","volume":"7","author":"Ola","year":"2016","journal-title":"Nat.Commun."},{"key":"10.1016\/j.vph.2018.10.005_bb0720","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ncb3534","article-title":"Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling","volume":"19","author":"Jin","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.vph.2018.10.005_bb0725","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCRESAHA.117.309930","article-title":"Deregulated TGF-\u03b2\/BMP signaling in vascular malformations","volume":"121","author":"Cunha","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2018.10.005_bb0730","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1709449","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0735","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation","volume":"100","author":"Couto","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.vph.2018.10.005_bb0740","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jvs.2011.06.098","article-title":"Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations","volume":"54","author":"Ye","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.vph.2018.10.005_bb0745","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00006123-199605000-00011","article-title":"Expression of angiogenic factors and structural proteins in central nervous system vascular malformations","volume":"38","author":"Rothbart","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.vph.2018.10.005_bb0750","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00005072-199611000-00003","article-title":"Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations","volume":"55","author":"Hatva","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.vph.2018.10.005_bb0755","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00006123-200005000-00032","article-title":"Expression of structural proteins and angiogenic factors in cerebrovascular anomalies","volume":"46","author":"Kili\u00e7","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.vph.2018.10.005_bb0760","first-page":"117","article-title":"Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations","volume":"50","author":"Koizumi","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.vph.2018.10.005_bb0765","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.034","article-title":"Alternatively activated macrophages play an important role in vascular remodeling and hemorrhaging in patients with brain arteriovenous malformation","volume":"25","author":"Nakamura","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.vph.2018.10.005_bb0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1227\/01.NEU.0000334417.56742.24","article-title":"Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells","volume":"64","author":"Jabbour","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.vph.2018.10.005_bb0775","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12013-014-9937-0","article-title":"Increased expression of angiogenic factors in cultured human brain arteriovenous malformation endothelial cells","volume":"70","author":"Xu","year":"2014","journal-title":"Cell Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0780","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jocn.2010.08.025","article-title":"Polymorphisms of the vascular endothelial growth factor A gene and susceptibility to sporadic brain arteriovenous malformation in a chinese population","volume":"18","author":"Chen","year":"2011","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0785","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2018.10.005_bb0790","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0303-8467(01)00112-3","article-title":"Treatment-induced neoangiogenesis in cerebral arteriovenous malformations","volume":"103","author":"Sure","year":"2001","journal-title":"Clin. Neurol. Neursurg."},{"key":"10.1016\/j.vph.2018.10.005_bb0795","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.surneu.2006.10.075","article-title":"The relationship between venous hypertension and expression of vascular endothelial growth factor: hemodynamic and immunohistochemical examinations in a rat venous hypertension model","volume":"68","author":"Kojima","year":"2007","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.vph.2018.10.005_bb0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4800(03)00032-7","article-title":"High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor","volume":"75","author":"Sho","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.vph.2018.10.005_bb0805","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2011.00014","article-title":"Vascular growth in health and disease","volume":"4","author":"Persson","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.vph.2018.10.005_bb0810","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jocn.2014.04.010","article-title":"Embolization-induced angiogenesis in cerebral arteriovenous malformations","volume":"21","author":"Buell","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.vph.2018.10.005_bb0815","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.vph.2018.10.005_bb0820","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1089\/scd.2012.0259","article-title":"Hypoxia-induced arterial differentiation requires adrenomedullin and notch signaling","volume":"22","author":"Lanner","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.vph.2018.10.005_bb0825","doi-asserted-by":"crossref","first-page":"e12167","DOI":"10.7554\/eLife.12167","article-title":"Synchronization of endothelial Dll4-notch dynamics switch blood vessels from branching to expansion","volume":"5","author":"Ubezio","year":"2016","journal-title":"elife"},{"key":"10.1016\/j.vph.2018.10.005_bb0830","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1073\/pnas.1415316111","article-title":"Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels","volume":"111","author":"Murphy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.10.005_bb0835","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1073\/pnas.0802743105","article-title":"Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice","volume":"105","author":"Murphy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.vph.2018.10.005_bb0840","doi-asserted-by":"crossref","first-page":"9884","DOI":"10.1073\/pnas.0504391102","article-title":"Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice","volume":"102","author":"Carlson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2018.10.005_bb0845","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1093\/brain\/awp246","article-title":"Notch-1 signalling is activated in brain arteriovenous malformations in humans","volume":"132","author":"ZhuGe","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.vph.2018.10.005_bb0850","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3892\/mmr.2014.2061","article-title":"Receptors of the Notch signaling pathway are associated with hemorrhage of brain arteriovenous malformations","volume":"9","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0855","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3171\/2016.3.JNS151731","article-title":"NOTCH4 gene polymorphisms as potential risk factors for brain arteriovenous malformation development and hemorrhagic presentation","volume":"126","author":"Delev","year":"2017","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb0860","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1227\/NEU.0b013e31822d9881","article-title":"Brain arteriovenous malformations are associated with interleukin-1 cluster gene polymorphisms","volume":"70","author":"Fontanella","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.vph.2018.10.005_bb0865","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000185609","article-title":"Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation","volume":"27","author":"Kim","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.vph.2018.10.005_bb0870","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2010.04.023","article-title":"The rs522616 polymorphism in the matrix metalloproteinase-3 (MMP-3) gene is associated with sporadic brain arteriovenous malformation in a Chinese population","volume":"17","author":"Zhao","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.vph.2018.10.005_bb0875","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000160215","article-title":"Population stratification in a case-control study of brain arteriovenous malformation in latinos","volume":"31","author":"Kim","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vph.2018.10.005_bb0880","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00234-014-1483-3","article-title":"Long-term results of ethanol sclerotherapy with or without adjunctive surgery for head and neck arteriovenous malformations","volume":"57","author":"Kim","year":"2015","journal-title":"Neuroradiology"},{"key":"10.1016\/j.vph.2018.10.005_bb0885","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3174\/ajnr.A3180","article-title":"Head and neck arteriovenous malformations: results of ethanol sclerotherapy","volume":"34","author":"Pekkola","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.vph.2018.10.005_bb0890","article-title":"Intranasal bevacizumab in the treatment of HHT \u2013 related epistaxis: a systematic review","author":"Stokes","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.vph.2018.10.005_bb0895","article-title":"Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review","author":"Halderman","year":"2018","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/j.vph.2018.10.005_bb0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188943","article-title":"Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): a retrospective study of 46 patients","volume":"12","author":"Guilhem","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vph.2018.10.005_bb0905","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2018.10.005_bb0910","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc4000","article-title":"MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road","volume":"15","author":"Caunt","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.vph.2018.10.005_bb0915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ctrv.2017.07.005","article-title":"Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: from laboratory to patients","volume":"59","author":"Janku","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.vph.2018.10.005_bb0920","doi-asserted-by":"crossref","first-page":"117ra8","DOI":"10.1126\/scitranslmed.3002670","article-title":"Notch4 normalization reduces blood vessel size in arteriovenous malformations","volume":"4","author":"Murphy","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.vph.2018.10.005_bb0925","doi-asserted-by":"crossref","first-page":"19071","DOI":"10.1073\/pnas.1310905110","article-title":"Reducing jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix gla protein","volume":"110","author":"Yao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0930","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jvs.2011.06.098","article-title":"Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations","volume":"54","author":"Ye","year":"2011","journal-title":"J. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0935","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2015.55","article-title":"Somatic activating RAS mutations cause vascular tumors including pyogenic granuloma","volume":"135","author":"Lim","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb0940","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosom. Cancer"},{"issue":"5","key":"10.1016\/j.vph.2018.10.005_bb0945","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ajpath.2013.01.012","article-title":"R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations","volume":"182","author":"Kurek","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0950","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation","volume":"100","author":"Couto","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0955","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.resinv.2013.08.003","article-title":"BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report","volume":"52","author":"Handa","year":"2014","journal-title":"Respir. Investig."},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb0960","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1709449","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0965","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jocn.2010.08.025","article-title":"Polymorphisms of the vascular endothelial growth factor A gene and susceptibility to sporadic brain arteriovenous malformation in a Chinese population","volume":"18","author":"Chen","year":"2011","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0970","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.033","article-title":"Angiopoietin-like proteins 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformation","volume":"27","author":"Erkinova","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb0975","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/01.STR.0000182253.91167.fa","article-title":"Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations","volume":"36","author":"Pawlikowska","year":"2005","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb0980","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3171\/jns.2006.104.6.945","article-title":"Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system","volume":"104","author":"Simon","year":"2006","journal-title":"J. Neurosurg."},{"issue":"9","key":"10.1016\/j.vph.2018.10.005_bb0985","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jocn.2011.02.010","article-title":"Susceptible gene single nucleotide polymorphism and hemorrhage risk in patients with brain arteriovenous malformation","volume":"18","author":"Jiang","year":"2011","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2018.10.005_bb0990","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000160215","article-title":"Population stratification in a case-control study of brain arteriovenous malformation in latinos","volume":"31","author":"Kim","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.vph.2018.10.005_bb0995","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000185609","article-title":"Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation","volume":"27","author":"Kim","year":"2009","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.vph.2018.10.005_bb1000","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1227\/NEU.0b013e31822d9881","article-title":"Brain arteriovenous malformations are associated with interleukin-1 cluster gene polymorphisms","volume":"70","author":"Fontanella","year":"2012","journal-title":"Neurosurgery"},{"issue":"12","key":"10.1016\/j.vph.2018.10.005_bb1005","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2010.04.023","article-title":"The rs522616 polymorphism in the matrix metalloproteinase-3 (MMP-3) gene is associated with sporadic brain arteriovenous malformation in a Chinese population","volume":"17","author":"Zhao","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.vph.2018.10.005_bb1010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.vph.2018.10.005_bb1015","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/humu.22431","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation","volume":"34","author":"Revencu","year":"2013","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.vph.2018.10.005_bb1020","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.116.026886","article-title":"Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling","volume":"136","author":"Amyere","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.vph.2018.10.005_bb1025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCRESAHA.117.309930","article-title":"Deregulated TGF-beta\/BMP signaling in vascular malformations","volume":"121","author":"Cunha","year":"2017","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb1030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/14728222.2017.1365839","article-title":"Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia","volume":"21","author":"Ruiz-Llorente","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.vph.2018.10.005_bb1035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2006.041517","article-title":"SMAD4 mutations found in unselected HHT patients","volume":"43","author":"Gallione","year":"2006","journal-title":"J. Med. Genet."},{"issue":"11","key":"10.1016\/j.vph.2018.10.005_bb1040","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ajmg.a.35622","article-title":"Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations","volume":"158A","author":"Nishida","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.vph.2018.10.005_bb1045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","article-title":"BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia","volume":"93","author":"Wooderchak-Donahue","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"19","key":"10.1016\/j.vph.2018.10.005_bb1050","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/ajmg.a.32468","article-title":"BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia","volume":"146A","author":"Rigelsky","year":"2008","journal-title":"Am. J. Med. Genet. A"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189118301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189118301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:18:56Z","timestamp":1761527936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189118301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":210,"alternative-id":["S1537189118301630"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2018.10.005","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}